date

Kaskade Finance Closes Successful Pre-Seed Round

Kaskade finance, a gamified incentivization layer protocol, just announced the closure of its pre-seed funding round from over 40 investors. Kaskade Finance Nathan Lenga, CEO of Kaskade, tabled the MVP to go live in August, and to continue to build a world-class team that will make certain Kaskade Finance is the premier liquidity incentivization layer for all of DeFi. The oversubscribed seed round had participation from over 40 investors, some of which include Marshland, NxGen.xyz, Artemis Capital, Andromeda Capital, Hercules Ventures, 369 Capital, Crypto Oasis Ventures, as well as influencers,

AYA and Blockpass Collaborate to Ensure Compliance and Security in a Green Tech Future

HONG KONG, Mar 6, 2024 - (ACN Newswire) - Blockpass is excited to announce a partnership with AYA, a regulated UAE-based fundraising platform focused on the intersection of blockchain and sustainability. Concerned with facilitating innovative solutions which encourage a greener future, AYA mentors and cultivates projects which combine the borderless, transparent nature of blockchain to further the goal of sustainablility and achieving the SDGs. This partnership will see Blockpass strengthening AYA's compliance procedures and providing: risk assessment and risk classification of onboarding customers, customized forms based on the customer's and

SHEQONOMI Partnership announced with Reliance JiO JioStore and KaiStore. 300K+ Downloads and Climbing.

Feb 12, 2023: San Juan, Puerto Rico. Global digital media and podcast listening multi-platform, SHEQONOMI proudly announces the launch of our newest mobile apps architected and built by women through global collaborations forged in response to the global COVID-19 Pandemic. We are thrilled to be amplifying the voices of several thousand women who have supported our vision since lockdown and now proudly feature content in English, Spanish, Chinese, Tagalog, Bahasa, Portuguese, Swedish, Norwegian, Icelandic, Bengali, Hindi, Gujarati, Tamil, Telugu, and more. Our curated content includes more than 30 genres including

Blockpass Heralds Cutting Edge Compliance Automation – Advanced KYC Bot(TM)

HONG KONG, Jan 18, 2024 - (ACN Newswire) - Blockpass is proud to reveal a brand-new automation advancement that will see the KYC experience for its customers improved even further with the introduction of the Advanced KYC Bot(TM). Included as standard for all Managed Service add-on clients, the handy new bot will automate the KYC process even further, reducing the time and effort required for compliance by monitoring and processing flags to KYC profiles. Also available on a standalone basis for Enterprise customers, the Advanced KYC Bot(TM) builds on the capability

Bitcoin, which goes hand in hand with AI technology, can we expect a continued bright outlook? 

Due to the full-scale introduction of AI technology in 2023, America's big tech companies such as Meta, Amazon, and Twitter are threatening human jobs by laying off more than 100,000 employees a year alone. In the aftermath of this, some experts say that the pace of AI development should be slowed down to prevent further harm to human jobs, but on the other hand, most experts believe that human development should proceed together in a society that coexists with AI, rather than slowing it down. There was also an opinion

Paribus Embracing DAO transition.

In our journey of developing Paribus, we’ve received a lot of feedback from our community, primarily positive and helpful. But, as is often the case when a small team controls a platform, not everyone agrees with our decisions. At every step, we’ve tried to make the best choices based on the information we had. We’ve always known that, eventually, it would be the community’s turn to take the lead in guiding Paribus. And, as we announced in our recent X-space update, that time is approaching fast with the release of

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

NEW APPEAL TO PROVIDE SUPPORT TO THOUSANDS OF ISRAELI CITIZENS FOLLOWING HAMAS ASSAULT

  Tel Aviv, New York & London; October 19, 2023: In the wake of the recent catastrophic and unprecedented attack that was launched at Israel by Hamas on and beyond October 7, Ahavat Yisroel Humanity Inc. has launched an urgent fundraising appeal in order to provide much-needed support and supplies to the thousands of Israeli citizens affected. The Israel Now, Israel Forever appeal is seeking donations to provide the many affected citizens with food, shelter, and urgent suppliers. The donations will be shared among four established and experienced relief organisations

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

Blockpass integrates award-winning ID system with Solana Wallets, offers special discount to Solana projects

HONG KONG, Sept 7, 2023 - (ACN Newswire) - Blockpass has announced that it will be integrating its identity verification solution with Solana Wallets and supporting Solana projects with its revolutionary On-Chain KYC(R) solution. Additionally, Blockpass will provide a unique special offer available to all Solana projects in the form of a 50% discount. Solana is a blockchain network with the fundamental ideals of an open-source community, decentralization, staking and censorship resistance at its heart. The Solana network is validated by thousands of independently-operating nodes that ensures data remains secure

American Picture House Corporate Update

New York, NY, Raleigh, NC, and Los Angeles, CA.  September 6, 2023 – American Picture House Corporation (OTC: APHP), an entertainment company with a focus on producing feature films, limited series, and entertainment enhancing technologies, today provided a corporate update for shareholders. Industry Strikes American Picture House supports the ideals behind the two current industry strikes -- brought by the Writers Guild of America (“WGA”) and the Screen Actors Guild (“SAG”) -- and joins the many reasonable voices urging for a fair and timely resolution. Update on Feature Films -